| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CALA (CALA) has 0 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. CALA is classified in the Diversified Financial Services industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2019 | Orford Keith | Chief Medical Officer | Sell | 1,565 | $6.00 | $9,390.00 | -12.2% | |
| Oct 15, 2018 | Orford Keith | Sr. VP, Clinical Development | Sell | 313 | $6.05 | $1,893.65 | -2.9% | |
| Oct 11, 2018 | Orford Keith | Sr. VP, Clinical Development | Sell | 1,252 | $6.00 | $7,512.00 | -10.5% | |
| Sep 28, 2017 | Adage Capital Partners Gp, L.l.c.64 | 10% Owner | Sell | 576,000 | $15.64 | $9,008,100.00 | -5.0% | |
| Jul 17, 2017 | Wong Stephanie | VP, Finance And Secretary | Sell | 3,552 | $18.41 | $65,384.51 | -25.2% | |
| Jul 17, 2017 | Orford Keith | Sr. VP, Clinical Development | Sell | 2,120 | $18.31 | $38,822.71 | -23.6% | |
| Jul 6, 2017 | Hecht Curtis | SVP, Bus. &Corp. Development | Sell | 700 | $18.00 | $12,600.00 | -4.2% | |
| May 19, 2017 | Hecht Curtis | SVP, Bus. &Corp. Development | Sell | 650 | $16.00 | $10,400.00 | -4.2% | |
| Mar 22, 2017 | Adage Capital Partners Gp, L.l.c.64 | 10% Owner | Buy | 487,804 | $10.25 | $4,999,991.00 | +13.4% | |
| Mar 13, 2017 | Hecht Curtis | SVP, Bus. &Corp. Development | Sell | 600 | $14.00 | $8,400.00 | -3.7% |